• Explore /
  • Poster
  • / The impact of patient-related factors on the occurrence of febrile neutropenia in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin, and cyclofosfamide (FEC) x6 or FEC x3 followed by docetaxel (D) x3.

The impact of patient-related factors on the occurrence of febrile neutropenia in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin, and cyclofosfamide (FEC) x6 or FEC x3 followed by docetaxel (D) x3.

Abstract Poster

Authors

null

Christof Vulsteke

University Hospitals Leuven, Department of General Medical Oncology, Leuven, Belgium

Christof Vulsteke , Alena Pfeil , Barbara Brouwers , Matthias Schwenkglenks , Robert Paridaens , Ruth Pettengell , Anne-Sophie Dieudonné , Sigrid Hatse , Patrick Neven , Diether Lambrechts , Hans Wildiers

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer - Triple-Negative/Cytotoxics/Local Therapy

Track

Breast Cancer

Sub Track

Cytotoxic Chemotherapy

Citation

J Clin Oncol 31, 2013 (suppl; abstr 1078)

DOI

10.1200/jco.2013.31.15_suppl.1078

Abstract #

1078

Poster Bd #

23E

Abstract Disclosures

Similar Posters

First Author: Yvonne Brandberg

First Author: Christof Vulsteke

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Metronomic oral cyclophosphamide as maintenance therapy in metastatic pancreatic ductal adenocarcinoma.

Metronomic oral cyclophosphamide as maintenance therapy in metastatic pancreatic ductal adenocarcinoma.

First Author: Michele Reni

First Author: Sofia Torres